Average Co-Inventor Count = 5.94
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (11 from 1,974 patents)
2. Ribon Therapeutics, Inc. (10 from 11 patents)
3. Boehringer Ingelheim International Gmbh (3 from 1,536 patents)
4. Teijin Pharma Limited (2 from 125 patents)
26 patents:
1. 12492185 - Benzimidazole derivatives and their uses
2. 12398146 - Heterobicyclic amides as inhibitors of CD38
3. 12371421 - Solid forms of a PARP7 inhibitor
4. 11987584 - Heterobicyclic amides as inhibitors of CD38
5. 11958837 - Quinazolinones as PARP14 inhibitors
6. 11952377 - Quinolines and azaquinolines as inhibitors of CD38
7. 11566020 - Pyridazinones as PARP7 inhibitors
8. 11535621 - Heterobicyclic amides as inhibitors of CD38
9. 11332459 - Benzimidazole derivatives and their uses
10. 11293927 - Screening methods for PARP modulators
11. 11014913 - Pyridazinones as PARP7 inhibitors
12. 11008308 - Quinazolinones as PARP14 inhibitors
13. 10870641 - Pyridazinones as PARP7 inhibitors
14. 10562891 - Quinazolinones as PARP14 inhibitors
15. 10550105 - Pyridazinones as PARP7 inhibitors